BCL partners David Hardstaff and John Binns have written for Food Navigator discussing how a high-profile investigation into banned muscle-building drugs highlights the issues with the novel food regime impacting the CBD industry.
BCL partner John Binns and senior associate David Hardstaff share their views on a blueprint for the UK Cannabis Industry in their recent article for Open Government Access.
BCL partner, John Binns discusses Interpol’s Operation Pangea – which illustrates how financial crime can be overcome – in the context of the global fight against illicit medicines, in his latest article for Open Access Government.
BCL partner John Binns and senior associate David Hardstaff write for Cannabis Wealth discussing the regulatory landscape in the UK following the EFSA’s decision to pause all novel foods evaluations for CBD products.
UK-based CBD companies may feel they have had a rough ride recently as the FSA introduces the new novel food application process, which requires non-medicinal CBD products to be the subject of an application for authorisation. BCL partner John Binns and senior associate David Hardstaff explore the changes in the UK CBD industry in their recent article for Open Government Access.
BCL Senior Associate, David Hardstaff and Partner, John Binns write for Open Access Government exploring the UK’s doomed Medical Cannabis (Access) Bill.
BCL partner John Binns and associate David Hardstaff ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD) in their article published by Open Access Government.
BCL partner John Binns’s article “High stakes: Is the UK finally clearing a pathway for cannabis investments?” has been published by Open Access Government.
